A

Acticor Biotech SA
PAR:ALACT

Watchlist Manager
Acticor Biotech SA
PAR:ALACT
Watchlist
Price: 0.4 EUR -2.44% Market Closed
Market Cap: 6.3m EUR
Have any thoughts about
Acticor Biotech SA?
Write Note

Acticor Biotech SA
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Acticor Biotech SA
Total Liabilities & Equity Peer Comparison

Comparables:
VLA
NANO
G
GNFT
ALERS
OSE

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
A
Acticor Biotech SA
PAR:ALACT
Total Liabilities & Equity
€9.7m
CAGR 3-Years
31%
CAGR 5-Years
3%
CAGR 10-Years
-11%
Valneva SE
PAR:VLA
Total Liabilities & Equity
€466.6m
CAGR 3-Years
-14%
CAGR 5-Years
13%
CAGR 10-Years
7%
Nanobiotix SA
PAR:NANO
Total Liabilities & Equity
€93.9m
CAGR 3-Years
-9%
CAGR 5-Years
5%
CAGR 10-Years
12%
G
Genfit SA
PAR:GNFT
Total Liabilities & Equity
€194.8m
CAGR 3-Years
13%
CAGR 5-Years
-10%
CAGR 10-Years
10%
Eurobio Scientific SA
PAR:ALERS
Total Liabilities & Equity
€316.3m
CAGR 3-Years
21%
CAGR 5-Years
35%
CAGR 10-Years
22%
OSE Immunotherapeutics SA
PAR:OSE
Total Liabilities & Equity
€140.9m
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
N/A

See Also

What is Acticor Biotech SA's Total Liabilities & Equity?
Total Liabilities & Equity
9.7m EUR

Based on the financial report for Dec 31, 2023, Acticor Biotech SA's Total Liabilities & Equity amounts to 9.7m EUR.

What is Acticor Biotech SA's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
-11%

Over the last year, the Total Liabilities & Equity growth was -25%. The average annual Total Liabilities & Equity growth rates for Acticor Biotech SA have been 31% over the past three years , 3% over the past five years , and -11% over the past ten years .

Back to Top